Clinical trial
Mercury Chelation to Treat Autism
NCT00376194 · National Institute of Mental Health (NIMH), NIH · Withdrawn
Key facts
| NCT number | NCT00376194 |
|---|---|
| Title | Mercury Chelation to Treat Autism |
| Official title | An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autism, Asperger's Disorder, Child Development Disorders, Pervasive |
| Intervention type | Drug |
| Interventions | DMSA |
| Enrollment | 0 |
| Start date | Sep 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Sep 14, 2006 |
| Last update posted | Sep 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: